This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Jong Hee Chae Articles by Ki Joong Kim Search for Related Content PubMed PubMed Citation Articles by Jong Hee Chae, Articles by Ki Joong Kim, Pubmed/NCBI databases Genetics Home Reference Genetics Home Reference - MECP2 Gene Medline Plus Health Information Rett Syndrome Social Bookmarking                         What's this?

Mutation Analysis of MECP2 and Clinical Characterization in Korean Patients With Rett Syndrome

Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea

Yong Seung Hwang, MD

Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea

Ki Joong Kim, MD

Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea, pednr{at}plaza.snu.ac.kr

Rett syndrome is a progressive neurodevelopmental disorder occurring predominantly in females. Recently, mutations in the MECP2 gene on Xq28, which encodes methyl-CpG binding protein 2, were identified as responsible for some cases of Rett syndrome. In the present study, we analyzed the entire coding sequence of the MECP2 gene in 20 sporadic cases of Rett syndrome in Korea. Of the 20 patients, 14 (70%) had pathogenic mutations, which included 10 different mutations. Altogether, there were five missense mutations (D97Y, L100V, R133C, T158M, R306C), four nonsense mutations (R168X, R255X, R270X, R294X), and one frameshift mutation (a 41-bp deletion at 1157-1197). Two of these were novel mutations (D97Y, L100V). Most of the nucleotide substitutions involved C to T transitions at CpG hotspots. We could find no clear phenotype-genotype correlation according to the type of mutation. However, there was a tendency for patients with no MECP2 mutation (30%) to show more severe symptoms and more rapid clinical progression than patients with mutations. Further studies are necessary to identify the other possible genetic causes of Rett syndrome. (J Child Neurol 2002;17:33-36).

Journal of Child Neurology, Vol. 17, No. 1, 33-36 (2002)
DOI: 10.1177/088307380201700108


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				J. L. Neul, P. Fang, J. Barrish, J. Lane, E. B. Caeg, E. O. Smith, H. Zoghbi, A. Percy, and D. G. Glaze Specific mutations in Methyl-CpG-Binding Protein 2 confer different severity in Rett syndrome Neurology, April 15, 2008; 70(16): 1313 - 1321. [Abstract] [Full Text] [PDF]